Presentation of the division
From Phase I to Phase IV and into real-world evidence (RWE) studies, our experts support you across the entire clinical lifecycle, including consumer studies, as well as early access and compassionate use programs. We drive your projects from initiation in the Start-Up phase through to close-out, ensuring rigorous monitoring and proactive risk management. Our integrated approach guarantees operational control and compliance at every stage of your development
Our expertise
Medical Writing & Medical Affairs
- Medical Writer
- Medical Project Manager
Project Management
- Contract & Budget Manager
- Study Start-Up Manager
- Clinical Research Manager
- Clinical Project Director
Monitoring & Promotion
- Clinical Research Associate (CRA) / Monitor
- Sponsor CRA / Hospital CRA
- Clinical Trial Assistant (CTA)
- Lead CRA / Monitoring Coordinator
Epidemiology & RWE
- Pharmacoepidemiology Project Manager
- RWE Study Project Manager
- Evidence Generation Manager
Market Access
- Market Access Project Manager
- Market Access Strategy Expert (Pricing & Reimbursement)
- Early Access & Compassionate Use Project Manager
Therapeutic Areas
- Pharmaceuticals
- Biotech
- Medical Devices
- Healthcare Facilities
- Cosmetics
- Nutrition
- Animal Health
Industries
-
Oncology & Hematology
-
Vaccines
-
Rare Diseases
-
Pulmonology
-
Immunology
-
Dermatology
-
Neuroscience
-
Cardio-metabolism
-
Allergology
-
Ophthalmology
FULL PRODUCT LIFECYCLE SUPPORT
Clinical Operations & Development
Our Achievements
IVIDATA Life Sciences: supporting you for over 10 years. Explore all our achievements.
Survival analysis of dental prostheses in real-life conditions
Observational Study of a Rare Lysosomal Disease: Epidemiological Analysis in France
IVIDATA Life Sciences supports the digitalization of clinical trials for a large pharmaceutical company
Optimising Early Post-MA Access for Rare Diseases: Data Management and Regulatory Support
